Literature DB >> 10930594

Association of L-DOPA with recovery following Ayurveda medication in Parkinson's disease.

N Nagashayana1, P Sankarankutty, M R Nampoothiri, P K Mohan, K P Mohanakumar.   

Abstract

Ayurveda, the Indian system of traditional medicine, uses a concoction of several spices, herbs and minerals for the treatment of diseases. In a clinical prospective study we have evaluated the efficacy of Ayurveda treatment (a concoction in cow's milk of powdered Mucuna pruriens and Hyoscyamus reticulatus seeds and Withania somnifera and Sida cordifolia roots) in 18 clinically diagnosed (with a mean Hoen and Yahr value of 2.22) parkinsonian patients. As per Ayurveda principles, 13 patients underwent both cleansing (for 28 days) and palliative therapy (56 days), 5 patients underwent palliative therapy alone (84 days). Only the former group showed significant improvement in activities of daily living (ADL) and on motor examination as per UPDRS rating. Symptomatically, they exhibited better response in tremor, bradykinesia, stiffness and cramps as compared to the latter group. Excessive salivation worsened in both the groups. Analyses of powdered samples in milk, as administered in patients, revealed about 200 mg of L-DOPA per dose. The study establishes the necessity of cleansing therapy in Ayurveda medication prior to palliative therapy. It also reveals contribution of L-DOPA in the recovery as observed in Parkinson' disease following Ayurveda medication.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10930594     DOI: 10.1016/s0022-510x(00)00329-4

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  24 in total

1.  Antiparkinsonian effects of aqueous methanolic extract of Hyoscyamus niger seeds result from its monoamine oxidase inhibitory and hydroxyl radical scavenging potency.

Authors:  T Sengupta; J Vinayagam; N Nagashayana; B Gowda; P Jaisankar; K P Mohanakumar
Journal:  Neurochem Res       Date:  2010-10-23       Impact factor: 3.996

2.  Ultrastructural and biochemical investigations of protein mobilization of Mucuna pruriens (L.) DC. cotyledons and embryo axis.

Authors:  Simonetta Muccifora; Roberto Guerranti; Chiara Muzzi; Nnadozies S Hope-Onyekwere; Roberto Pagani; Roberto Leoncini; Lorenza M Bellani
Journal:  Protoplasma       Date:  2009-10-27       Impact factor: 3.356

3.  Neuroprotective role of Withania somnifera root extract in maneb-paraquat induced mouse model of parkinsonism.

Authors:  Jay Prakash; Satyndra Kumar Yadav; Shikha Chouhan; Surya Pratap Singh
Journal:  Neurochem Res       Date:  2013-02-22       Impact factor: 3.996

4.  A water extract of Mucuna pruriens provides long-term amelioration of parkinsonism with reduced risk for dyskinesias.

Authors:  Christopher A Lieu; Allen R Kunselman; Bala V Manyam; Kala Venkiteswaran; Thyagarajan Subramanian
Journal:  Parkinsonism Relat Disord       Date:  2010-05-31       Impact factor: 4.891

5.  Propensity of Withania somnifera to Attenuate Behavioural, Biochemical, and Histological Alterations in Experimental Model of Stroke.

Authors:  Abhilasha Sood; Aditya Kumar; Devinder K Dhawan; Rajat Sandhir
Journal:  Cell Mol Neurobiol       Date:  2015-12-30       Impact factor: 5.046

6.  Chlorinated Withanolides from Withania somnifera.

Authors:  Xiaoqin Tong; Huaping Zhang; Barbara N Timmermann
Journal:  Phytochem Lett       Date:  2011-12       Impact factor: 1.679

Review 7.  An assessment of potential nutritive and medicinal properties of Mucuna pruriens: a natural food legume.

Authors:  Ruhi Pathania; Prince Chawla; Huma Khan; Ravinder Kaushik; Mohammed Azhar Khan
Journal:  3 Biotech       Date:  2020-05-20       Impact factor: 2.406

8.  Antiperoxidative and antiinflammatory effect of Sida cordifolia Linn. on quinolinic acid induced neurotoxicity.

Authors:  S S Swathy; Seema Panicker; R S Nithya; M M Anuja; S Rejitha; M Indira
Journal:  Neurochem Res       Date:  2010-05-25       Impact factor: 3.996

9.  Mucuna pruriens in Parkinson's disease: a double blind clinical and pharmacological study.

Authors:  R Katzenschlager; A Evans; A Manson; P N Patsalos; N Ratnaraj; H Watt; L Timmermann; R Van der Giessen; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-12       Impact factor: 10.154

10.  Neuroprotective Effects of Withania somnifera on 4-Hydroxynonenal Induced Cell Death in Human Neuroblastoma SH-SY5Y Cells Through ROS Inhibition and Apoptotic Mitochondrial Pathway.

Authors:  Maqsood A Siddiqui; Nida N Farshori; Mai M Al-Oqail; Aditya B Pant; Abdulaziz A Al-Khedhairy
Journal:  Neurochem Res       Date:  2020-10-14       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.